This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 02/26/2024
Location: Virtual
Subject: AIRIS 2024 (AI Regulatory and International Symposium) - Use of AI in Medical Product Development; Opening Ceremony
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, and other registered guests

Event Date: 02/29/2024
Location: Silver Spring, MD
Subject: Evidence Generation
FDA Participant/Group: ANDREW ZACHER;
Non FDA Participant/Group: David Faigenbaum, Grant Mitchell (Every Cure);

Event Date: 03/01/2024
Location: Virtual
Subject: FDA Rare Disease Day 2024
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered guests

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

Event Date: 02/27/2024
Location: Little Rock, AR
Subject: Arkansas Bioinformatics Consortium (AR-BIC) Conference; Speaker: Dialog with FDA Incoming Principal Deputy Commissioner
FDA Participant/Group: TUCKER PATTERSON;
Non FDA Participant/Group: Attendees of the Arkansas Collaborative Community in Bioinformatics Research

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 02/27/2024
Location: Washington, DC
Subject: Institute of Food Technologists: Food Policy Impact Conference; Speaker: FDA Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, non-profit organizations, students, and government

Event Date: 03/01/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: BARBARA CASSENS; CATHERINE MCDERMOTT; ERIK METTLER; DANIEL RICE; STEVEN MUSSER;
Non FDA Participant/Group: Scott Becker, Shari Shea (Association of Public Health Laboratories);

Event Date: 03/01/2024
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: STEVEN GRUBE; REBECCA BUCKNER; JANESIA ROBBS; LATASHA ROBINSON;
Non FDA Participant/Group: Art Pike, Audrae Erickson, Robert Cleveland (Mead Johnson Nutrition Company);

Event Date: 03/01/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: JANESIA ROBBS; REBECCA BUCKNER; ROBIN MCKINNON;
Non FDA Participant/Group: Jerold Mande (Nourish Science);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/26/2024
Location: Virtual
Subject: University of Florida's Bench2Market Regenerative Medicine Course; Regenerative Medicine and Cell-Based Therapies at the Center for Biologics Evaluation and Research
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the University of Florida's Bench2Market Regenerative Medicine Course

Event Date: 02/28/2024
Location: Virtual
Subject: Innovative Health Initiative Regulatory Science Summit 2024; Roundtable Discussion
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Innovative Health Initiative Regulatory Science Summit 2024

Event Date: 02/29/2024
Location: Virtual
Subject: Washington University School of Medicine in St. Louis Rare Disease Day Symposium; Leveraging Accelerated Approval and Other Regulatory Tools to Expedite Gene Therapy Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Washington University School of Medicine in St. Louis Rare Disease Day Symposium

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 02/27/2024
Location: Paris, France
Subject: Alternatives to Antimicrobials and Other Topics of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the World Organization for Animal Health (WOAH) Working Group

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 02/27/2024
Location: Tampa, FL
Subject: Convenience Distribution Association (CDA) Conference; Keynote: Tobacco Product Regulations: Insights from the Director of FDA’s Center for Tobacco Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, and other stakeholders

Event Date: 02/27/2024
Location: Tampa, FL
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Convenience Distribution Association (CDA) leadership

Event Date: 02/28/2024
Location: Virtual
Subject: FDA Tobacco Publication Education and Communication
FDA Participant/Group: N/A
Non FDA Participant/Group: Senate Health, Education, Labor and Pensions (HELP) staff

Event Date: 02/29/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of Guidehouse

Event Date: 02/29/2024
Location: Virtual
Subject: 8th Global Tobacco Regulators Forum Planning and Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Global Tobacco Regulators Forum (GTRF) Steering Committee

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 02/29/2024
Location: Laurel, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Generic Animal Drug Alliance (GADA)

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event